Host genetic determinants of Neisseria meningitidis infections - PubMed (original) (raw)
Review
Host genetic determinants of Neisseria meningitidis infections
M Emonts et al. Lancet Infect Dis. 2003 Sep.
Erratum in
- Lancet Infect Dis. 2003 Dec;3(12):815
Abstract
The clinical presentation of infections caused by Neisseria meningitidis is highly diverse. Some patients develop meningitis, and others present with sepsis or even septic shock. After invasion of the bloodstream by the bacteria, three main cascade pathways are activated. These are the complement system, the inflammatory response, and the coagulation and fibrinolysis pathway. These pathways do not act independently but are able to interact with each other. Genetic polymorphisms among components of these pathways have been shown to be involved in the susceptibility, severity, and outcome of meningococcal disease. We review knowledge of genetic variations associated with susceptibility to and severity of meningococcal infection. Complement deficiencies and defects in sensing or opsonophagocytic pathways, such as the rare Toll-like receptor 4 single nucleotide polymorphisms (SNPs) and combinations of inefficient variants of Fcgamma-receptors, seem to have the most important role in genetically established susceptibility. Effect on severity has repeatedly been reported for FcgammaRIIa and plasminogen activator inhibitor type 1 (PAI1) polymorphisms. Outcome effects have been confirmed for SNPs in properdin deficiencies, PAI1 and combination of the -511C/T SNP in interleukin 1beta, and the +2018C/T SNP in interleukin RN. Conflicting results are reported for the effect of the -308G/A promoter polymorphism in tumour necrosis factor (TNF) alpha. These differences may reflect discrepancies in group definitions between studies or the influence of additional SNPs in the TNFalpha promoter, which can form haplotypes representing different cytokine production capacity. For several SNPs, the potential effect on susceptibility, severity, or outcome has not yet been confirmed in an independent study.
Similar articles
- Current concepts in the role of the host response in Neisseria meningitidis septic shock.
Brandtzaeg P, van Deuren M. Brandtzaeg P, et al. Curr Opin Infect Dis. 2002 Jun;15(3):247-52. doi: 10.1097/00001432-200206000-00006. Curr Opin Infect Dis. 2002. PMID: 12015458 Review. - Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children.
Allen A, Obaro S, Bojang K, Awomoyi AA, Greenwood BM, Whittle H, Sirugo G, Newport MJ. Allen A, et al. Pediatr Infect Dis J. 2003 Nov;22(11):1018-9. doi: 10.1097/01.inf.0000095431.15606.68. Pediatr Infect Dis J. 2003. PMID: 14628773 No abstract available. - Analysis of TLR2, TLR4, and TLR9 single nucleotide polymorphisms in children with bacterial meningitis and their healthy family members.
Gowin E, Świątek-Kościelna B, Kałużna E, Nowak J, Michalak M, Wysocki J, Januszkiewicz-Lewandowska D. Gowin E, et al. Int J Infect Dis. 2017 Jul;60:23-28. doi: 10.1016/j.ijid.2017.04.024. Epub 2017 May 6. Int J Infect Dis. 2017. PMID: 28487240 - A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2.
Pridmore AC, Wyllie DH, Abdillahi F, Steeghs L, van der Ley P, Dower SK, Read RC. Pridmore AC, et al. J Infect Dis. 2001 Jan 1;183(1):89-96. doi: 10.1086/317647. Epub 2000 Nov 10. J Infect Dis. 2001. PMID: 11076707 - Host response to Neisseria meningitidis lacking lipopolysaccharides.
Brandtzaeg P. Brandtzaeg P. Expert Rev Anti Infect Ther. 2003 Dec;1(4):589-96. doi: 10.1586/14787210.1.4.589. Expert Rev Anti Infect Ther. 2003. PMID: 15482156 Review.
Cited by
- Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy.
Neri A, Fabiani M, Barbui AM, Vocale C, Miglietta A, Fazio C, Carannante A, Palmieri A, Vacca P, Ambrosio L, Stefanelli P. Neri A, et al. Vaccines (Basel). 2022 May 14;10(5):778. doi: 10.3390/vaccines10050778. Vaccines (Basel). 2022. PMID: 35632534 Free PMC article. - Acute kidney injury in a mouse model of meningococcal disease.
Kolbe KR, Sanches TR, Fanelli C, Garnica MR, Urbano de Castro L, Gooch K, Thomas S, Taylor S, Gorringe A, Noronha IL, Andrade L. Kolbe KR, et al. Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211056507. doi: 10.1177/20587384211056507. Int J Immunopathol Pharmacol. 2021. PMID: 34930061 Free PMC article. - Cell Type Specific Expression of Toll-Like Receptors in Human Brains and Implications in Alzheimer's Disease.
Frederiksen HR, Haukedal H, Freude K. Frederiksen HR, et al. Biomed Res Int. 2019 Jul 18;2019:7420189. doi: 10.1155/2019/7420189. eCollection 2019. Biomed Res Int. 2019. PMID: 31396533 Free PMC article. Review. - A Functional Polymorphism-Mediated Disruption of EGR1/ADAM10 Pathway Confers the Risk of Sepsis Progression.
Chen F, Wang Y, Zhang W, Cai Y, Zhao T, Mai H, Tao S, Wei W, Li J, Chen X, Li X, Tang P, Fan W, Yang J, Ou M, Lu F, Lai Z, Chen H, Zou T, Sun F, Shao Y, Cui L. Chen F, et al. mBio. 2019 Aug 6;10(4):e01663-19. doi: 10.1128/mBio.01663-19. mBio. 2019. PMID: 31387910 Free PMC article. - Biosynthetic homeostasis and resilience of the complement system in health and infectious disease.
Willems E, Alkema W, Keizer-Garritsen J, Suppers A, van der Flier M, Philipsen RHLA, van den Heuvel LP, Volokhina E, van der Molen RG, Herberg JA, Levin M, Wright VJ, Ahout IML, Ferwerda G, Emonts M, Boeddha NP, Rivero-Calle I, Torres FM, Wessels HJCT, de Groot R, van Gool AJ, Gloerich J, de Jonge MI. Willems E, et al. EBioMedicine. 2019 Jul;45:303-313. doi: 10.1016/j.ebiom.2019.06.008. Epub 2019 Jun 29. EBioMedicine. 2019. PMID: 31262714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous